May 2007
Volume 48, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2007
Retinal and Choroidal Vascular Changes in VEGF Transgenic Models of Retinal Neovascularisation
Author Affiliations & Notes
  • M. C. Lai
    The University of Western Australia, Nedlands, Australia
    Centre for Ophthalmology and Visual Science,
    Molecular Ophthalmology,
    Lions Eye Institute, Perth, Australia
  • L. Tee
    The University of Western Australia, Nedlands, Australia
    School of Animal Biology,
  • M. Penrose
    The University of Western Australia, Nedlands, Australia
    School of Animal Biology,
  • J. E. O’Shea,
    The University of Western Australia, Nedlands, Australia
    School of Animal Biology,
  • E. P. Rakoczy
    The University of Western Australia, Nedlands, Australia
    Centre for Ophthalmology and Visual Science,
    Department of Molecular Ophthalmology,
    Lions Eye Institute, Perth, Australia
  • S. A. Dunlop
    The University of Western Australia, Nedlands, Australia
    School of Animal Biology,
    Western Australian Institute for Medical Research,
  • Footnotes
    Commercial Relationships M.C. Lai, None; L. Tee, None; M. Penrose, None; J.E. O’Shea,, None; E.P. Rakoczy, None; S.A. Dunlop, None.
  • Footnotes
    Support NHMRC and JDRFI
Investigative Ophthalmology & Visual Science May 2007, Vol.48, 3412. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M. C. Lai, L. Tee, M. Penrose, J. E. O’Shea,, E. P. Rakoczy, S. A. Dunlop; Retinal and Choroidal Vascular Changes in VEGF Transgenic Models of Retinal Neovascularisation. Invest. Ophthalmol. Vis. Sci. 2007;48(13):3412.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose:: We have recently developed three transgenic models of retinal neovascularisation with different levels of VEGF expression which correlated with the degree of damage to the retinal vasculature. trVEGF029 had either low or medium VEGF levels and damage to the retinal vasculature which was, respectively, either mild or moderate; VEGF levels in trVEGF056 were high and damage was severe. Here we compare the damage observed within the retinal vasculature in each model with that in the choroid.

Methods:: The severity of retinal neovascularisation in each model was confirmed by fundus fluorescein photography (FFA). We used confocal microscopy of Griffonia simplicifolia lectin-stained wholemounts to reveal the retinal vasculature and scanning electron microscopy of Mercox corrosion casts to examine the choroidal vasculature.

Results:: In transgenics, FFA confirmed vascular leakage which was mild, moderate or severe in the three models. Similarly, analysis of the retinal vasculature showed changes including microaneurysms, leukostasis and capillary dropout which were progressively worse in the mild, moderate and severe phenotypes. Changes within the choroid included mircoanuerysms, capillary constrictions and dropout within the capillaries of the choriocapillaris; within the major vessels, tortuosity and loops were observed while loss of venules and arterioles also occurred. Similar to the retinal vasculature, damage within the choroid was progressively worse in the mild, moderate and severe phenotypes.

Conclusions:: Despite the lack of diabetes in our models, choroidal abnormalities closely mimicked those seen in human diabetic retinopathy. Furthermore, the severity of choroidal damage in our models correlated with extent of retinal vascular leakage, i.e. increasing VEGF levels induced greater damage in both the retinal and choroidal vasculatures. The findings indicate that varying levels of VEGF trigger graded pathophysiological changes in both vascular beds. We suggest that the level of VEGF expression may contribute to different degrees of vascular damage in human diabetes and that control of VEGF and/or other angiogenic factors could significantly improve management of diabetic retinopathy patients.

Keywords: transgenics/knock-outs • neovascularization 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×